About Us
Adgyl Lifesciences is a leading global contract research organisation with over 30 years of GLP experience and is a preferred partner of Eurofins, a world leader in analytical testing. We have strong expertise in preclinical toxicology/safety assessment services, with a focus on data reliability and accuracy.
Overview and Role
A Global Preclinical Research Partner
We offer integrated services across drug discovery, preclinical development, including bioanalytical testing, which help Pharma and Biotech companies in global regulatory registrations. We provide safety and efficacy studies of agrochemicals, as well as safety assessment of cosmetics, nutraceuticals, and specialty and industrial chemicals.
Adgyl Lifesciences is a Multi-Faceted contract research organization with over three decades of experience in GLP-compliant non-clinical research.
Adgyl Lifesciences is a Multi-Faceted contract research organization with over three decades of experience in GLP-compliant non-clinical research.
We offer integrated services across drug discovery, preclinical development, including bioanalytical testing, which help Pharma and Biotech companies in global regulatory registrations. We provide safety and efficacy studies of agrochemicals, as well as safety assessment of cosmetics, nutraceuticals, and specialty and industrial chemicals.
Our Role
Supporting Critical Stages of Drug Development
We offer integrated services across drug discovery, preclinical development, including bioanalytical testing, which help Pharma and Biotech companies in global regulatory registrations. We provide safety and efficacy studies of agrochemicals, as well as safety assessment of cosmetics, nutraceuticals, and specialty and industrial chemicals.
Our History
A Legacy of Scientific and Regulatory Progress
1987
Adgyl Lifesciences test facility has a rich history dating back to 1987, when it began its operations under its previous avatars. In 2024, Adgyl Lifesciences was established as a separate business entity to offer integrated drug development and bioanalytical services.
1990s–2000s
Expansion of pharmacology and toxicology research
2010s
Increased regulatory exposure, including US FDA-linked inspections
2020s–Present
Integrated discovery and non-clinical support aligned globally
Regulatory Experience
Decades of Regulated Research Excellence
Backed by more than 300 IND/NDA studies and over 30,000 regulatory studies, we combine scientific depth with reliable, and scalable execution. Our facility has been audited twice by the US FDA and maintains complete OECD GLP compliance with NGCMA accreditation. We’ve also met the GLP standards of the Netherlands and Germany—reinforcing strong alignment with global regulatory expectations. We consistently deliver toptier research that meets the demands of multiple regulatory agencies
The facility has undergone regulatory inspections, including audits by the United States Food and Drug Administration, in connection with non-clinical toxicology studies submitted to support Phase I clinical trials. This history reflects long-standing adherence to Good Laboratory Practice (GLP) principles and data integrity standards.
Access Research Resources
Access regulatory insights, publications, and technical resources showcasing Adgyl’s research expertise.
Explore Scientific Services
Explore Adgyl’s pharmacology, toxicology, & bioanalytical services supporting discovery to regulatory submission.
Research Impact
Research Scale Across Regulated Programs
Our experience is reflected in the scale and breadth of regulated studies executed over decades of operation.
6000+
Acute Toxicology Studies
2,000+
Repeat Dose Toxicology Studies
700+
Developmental and Reproductive Toxicology Studies
75+
Carcinogenicity Studies
300+
IND/NDA Packages
250+
GMP Campaigns
1000+
Pharmacokinetic (PK) Studies
1,500+
Formulation Analysis
6,000+
Acute Toxicology Studies
2,000+
Repeat Dose Toxicology Studies
700+
Developmental and Reproductive Toxicology Studies
75+
Carcinogenicity Studies
300+
IND/NDA Packages
250+
GMP Campaigns
1000+
Pharmacokinetic (PK) Studies
1,500+
Formulation Analysis
Our Experts
Scientific Leadership and Multidisciplinary Expertise
Our technical team brings together a strong group of experts, including Diplomate of the American Board of Toxicology (DABT)–certified toxicologists,
European Registered Toxicologists (ERTs), and PhD professionals who carry an average of 14 years of experience.
In addition, our capabilities are strengthened by more than 200 highly experienced scientists and 60 study directors, each contributing over 12 years of professional expertise. We also have an in house team of pathologists with a combined experience of more than 125 years (4 pathologists ~18 yrs each + one with 40+ yrs + one with 26 yrs), providing expert support in study design, execution, interpretation, and reporting.
Quality Framework
Built on Quality, Ethics, and Regulatory Compliance
We follow ALCOA+ principles and maintain an independent, dedicated QA team to ensure full GLP compliance and data integrity. Our framework emphasizes defect prevention through robust document control, comprehensive training, scheduled audits, and method/equipment validation. With decades of GLP experience and a track record of compliance across multiple international regulatory authorities, we uphold a strong quality culture that ensures consistent, audit‑ready, and scientifically reliable study outcomes.
Data integrity framework
Ensuring accuracy, traceability, and confidence in every dataset
Adgyl operates under a robust data integrity framework aligned with GLP principles, ensuring data is attributable, legible, contemporaneous, original, and accurate (ALCOA+).
Security framework
Protecting research data, systems, and intellectual property
Our security framework is designed to protect confidential research data and sponsor information.
Digitization
Digitally enabled research for efficiency and compliance
Adgyl leverages digitized workflows and validated electronic systems to support study execution.
EHS
Safe, responsible research environments for people and science
Environmental, Health, and Safety (EHS) practices are embedded into Adgyl’s operations.
Accreditations
Recognized Certifications and Regulatory Credentials
Over 30 years of OECD GLP certification, combined with AAALAC accreditation (since 2001), OLAW assurance (since 2020), ISO 17025:2017 certification, DSIR recognition, CDSCO approval, CPCSEA registration, and ANAB accreditation, position us as a premier facility committed to quality, ethical compliance, and global regulatory alignment.
